rs146180696
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017671.5(FERMT1):c.910G>T(p.Glu304*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000125 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
FERMT1
NM_017671.5 stop_gained
NM_017671.5 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 5.03
Genes affected
FERMT1 (HGNC:15889): (FERM domain containing kindlin 1) This gene encodes a member of the fermitin family, and contains a FERM domain and a pleckstrin homology domain. The encoded protein is involved in integrin signaling and linkage of the actin cytoskeleton to the extracellular matrix. Mutations in this gene have been linked to Kindler syndrome. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-6097571-C-A is Pathogenic according to our data. Variant chr20-6097571-C-A is described in ClinVar as [Pathogenic]. Clinvar id is 224173.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-6097571-C-A is described in Lovd as [Pathogenic]. Variant chr20-6097571-C-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FERMT1 | NM_017671.5 | c.910G>T | p.Glu304* | stop_gained | 7/15 | ENST00000217289.9 | NP_060141.3 | |
FERMT1 | XM_024451935.2 | c.910G>T | p.Glu304* | stop_gained | 7/15 | XP_024307703.1 | ||
FERMT1 | XM_047440259.1 | c.910G>T | p.Glu304* | stop_gained | 7/15 | XP_047296215.1 | ||
FERMT1 | XM_047440260.1 | c.625G>T | p.Glu209* | stop_gained | 6/14 | XP_047296216.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152146Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251350Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135842
GnomAD3 exomes
AF:
AC:
16
AN:
251350
Hom.:
AF XY:
AC XY:
8
AN XY:
135842
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461830Hom.: 0 Cov.: 31 AF XY: 0.000113 AC XY: 82AN XY: 727218
GnomAD4 exome
AF:
AC:
194
AN:
1461830
Hom.:
Cov.:
31
AF XY:
AC XY:
82
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74314
GnomAD4 genome
AF:
AC:
7
AN:
152146
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Kindler syndrome Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | Common pathogenic variant - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 24, 2017 | The FERMT1 c.910G>T (p.Glu304Ter) variant is a stop-gained variant reported in a total of ten individuals with Kindler syndrome, including five homozygotes and five compound heterozygotes (Lanschuetzer et al. 2003; Lai-Cheong et al. 2008; Has et al. 2009; Techanukul et al. 2011; Youssefian et al. 2015). The variant was absent from a total of 200 control chromosomes but is reported at a frequency of 0.00012 in the European (non-Finnish) population of the Exome Aggregation Consortium. Has et al. (2009) showed that expression of kindlin-1, the protein produced by FERMT1, was absent in primary keratinocytes from a individual homozygous for the p.Glu304Ter variant as well as a individual compound heterozygous for p.Glu304Ter and a second stop-gained variant. Based on the potential impact of stop-gained variants and the evidence from the literature, the p.Glu304Ter variant is classified as pathogenic for Kindler syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
FERMT1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 01, 2024 | The FERMT1 c.910G>T variant is predicted to result in premature protein termination (p.Glu304*). This variant has been reported in the homozygous or compound heterozygous state in individuals affected with Kindler syndrome (see for example, Lanschuetzer et al. 2003. PubMed ID: 14507403; Has et al. 2009. PubMed ID: 19762715; Lai-Cheong et al. 2009. PubMed ID: 19762710; Heinemann et al. 2011. PubMed ID: 21309038). This variant is reported in 0.012% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in FERMT1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | This sequence change creates a premature translational stop signal (p.Glu304*) in the FERMT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FERMT1 are known to be pathogenic (PMID: 14962093, 21936020). This variant is present in population databases (rs146180696, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with clinical features of Kindler syndrome (PMID: 14507403). ClinVar contains an entry for this variant (Variation ID: 224173). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at